Planned Randomized Conversion From Tacrolimus to Sirolimus‐Based Immunosuppressive Regimen in De NovoKidney Transplant Recipients

Autor: Silva, H. T., Felipe, C. R., Garcia, V. D., Neto, E. D., Filho, M. A., Contieri, F. L. C., de Carvalho, D. D. B. M., Pestana, J. O. M.
Zdroj: American Journal of Transplantation; December 2013, Vol. 13 Issue: 12 p3155-3163, 9p
Abstrakt: In this multicenter, randomized, open‐label study, the authors show that planned conversion from tacrolimus to sirolimus 3 months after kidney transplantation was not associated with improved renal function or histological structure at 24 months.
Databáze: Supplemental Index